Sandra Mrozińska

499 total citations
34 papers, 380 citations indexed

About

Sandra Mrozińska is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Sandra Mrozińska has authored 34 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Sandra Mrozińska's work include Diabetes Management and Research (8 papers), Pancreatic function and diabetes (8 papers) and Ovarian function and disorders (7 papers). Sandra Mrozińska is often cited by papers focused on Diabetes Management and Research (8 papers), Pancreatic function and diabetes (8 papers) and Ovarian function and disorders (7 papers). Sandra Mrozińska collaborates with scholars based in Poland and Austria. Sandra Mrozińska's co-authors include Elżbieta Broniatowska, Anetta Undas, Maciej T. Małecki, Tomasz Klupa, Agnieszka H. Ludwig‐Słomczyńska, Bartłomiej Matejko, Tomasz Gosiewski, Przemysław Kapusta, Małgorzata Bulanda and Agnieszka Sroka-Oleksiak and has published in prestigious journals such as Blood, Diabetes and Scientific Reports.

In The Last Decade

Sandra Mrozińska

31 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Mrozińska Poland 11 129 109 77 75 69 34 380
D. Vogelaers Belgium 7 42 0.3× 99 0.9× 21 0.3× 19 0.3× 33 0.5× 12 349
T. B. Paul Geurts Netherlands 11 67 0.5× 251 2.3× 17 0.2× 43 0.6× 12 0.2× 20 442
Emma Pinjić United States 7 61 0.5× 194 1.8× 7 0.1× 9 0.1× 50 0.7× 8 350
Aleksandra Rymarz Poland 11 31 0.2× 43 0.4× 91 1.2× 18 0.2× 51 0.7× 48 319
Sikandar Hayat Khan Pakistan 8 163 1.3× 209 1.9× 36 0.5× 47 0.6× 51 0.7× 31 518
Nesibe Akyürek Türkiye 10 55 0.4× 98 0.9× 26 0.3× 39 0.5× 38 0.6× 34 249
H. Farouk Sadiq United States 10 63 0.5× 38 0.3× 27 0.4× 30 0.4× 90 1.3× 12 384
Sergio Parco Italy 12 81 0.6× 10 0.1× 25 0.3× 18 0.2× 37 0.5× 27 428
A. Tuzcu Türkiye 8 51 0.4× 105 1.0× 135 1.8× 15 0.2× 38 0.6× 12 403
B Cauliez France 12 94 0.7× 44 0.4× 26 0.3× 36 0.5× 71 1.0× 26 441

Countries citing papers authored by Sandra Mrozińska

Since Specialization
Citations

This map shows the geographic impact of Sandra Mrozińska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Mrozińska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Mrozińska more than expected).

Fields of papers citing papers by Sandra Mrozińska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Mrozińska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Mrozińska. The network helps show where Sandra Mrozińska may publish in the future.

Co-authorship network of co-authors of Sandra Mrozińska

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Mrozińska. A scholar is included among the top collaborators of Sandra Mrozińska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Mrozińska. Sandra Mrozińska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mrozińska, Sandra, et al.. (2022). Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump. International Journal of Endocrinology. 2022. 1–7. 15 indexed citations
2.
3.
Mrozińska, Sandra, Przemysław Kapusta, Tomasz Gosiewski, et al.. (2021). The Gut Microbiota Profile According to Glycemic Control in Type 1 Diabetes Patients Treated with Personal Insulin Pumps. Microorganisms. 9(1). 155–155. 19 indexed citations
4.
Tota, Łukasz, Bartłomiej Matejko, Wanda Pilch, et al.. (2021). Changes in Oxidative and Nitrosative Stress Indicators and Vascular Endothelial Growth Factor After Maximum-Intensity Exercise Assessing Aerobic Capacity in Males With Type 1 Diabetes Mellitus. Frontiers in Physiology. 12. 672403–672403. 6 indexed citations
5.
Mrozińska, Sandra, Tomasz Gosiewski, Agnieszka Sroka-Oleksiak, et al.. (2020). The effect of linagliptin treatment on gut microbiota in patients with HNF1A-MODY or type 2 diabetes — a preliminary cohort study. Clinical Diabetology. 8(6). 263–270. 2 indexed citations
6.
Matejko, Bartłomiej, Łukasz Tota, Sandra Mrozińska, et al.. (2020). Predictors of the maximal oxygen consumption in adult patients with type 1 diabetes treated with personal insulin pumps. Journal of Diabetes Investigation. 12(8). 1377–1385. 5 indexed citations
7.
8.
Szopa, Magdalena, Bartłomiej Matejko, Jerzy Hohendorff, et al.. (2018). Quality of life assessment in patients with HNF1A-MODY and GCK-MODY. Endocrine. 64(2). 246–253. 8 indexed citations
9.
Salamon, Dominika, Agnieszka Sroka-Oleksiak, Przemysław Kapusta, et al.. (2018). Characteristics of the gut microbiota in adult patients with type 1 and 2 diabetes based on the analysis of a fragment of 16S rRNA gene using next-generation sequencing.. Polskie Archiwum Medycyny Wewnętrznej. 128(6). 336–343. 81 indexed citations
10.
Mrozińska, Sandra, et al.. (2018). Elevated leptin and decreased adiponectin independently predict the post-thrombotic syndrome in obese and non-obese patients. Scientific Reports. 8(1). 6938–6938. 15 indexed citations
11.
Mrozińska, Sandra, et al.. (2018). The PCOS Patients differ in Lipid Profile According to their Phenotypes. Experimental and Clinical Endocrinology & Diabetes. 126(7). 437–444. 17 indexed citations
12.
Mrozińska, Sandra, et al.. (2017). Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study. Blood. 131(7). 797–807. 75 indexed citations
13.
Milewicz, Tomasz, et al.. (2017). Pressure pain threshold and β-endorphins plasma level are higher in lean polycystic ovary syndrome women. Minerva Endocrinology. 42(4). 297–305. 8 indexed citations
14.
Baran, Anna, et al.. (2017). [The influence of living conditions and lifestyle on the anxiety level in women in the postpartum period-questionnaire study].. PubMed. 74(3). 101–5. 1 indexed citations
15.
Milewicz, Tomasz, et al.. (2016). Basic and Meal Stimulated Plasma GIP Levels are Higher in Lean PCOS Women with FAI over 5. Experimental and Clinical Endocrinology & Diabetes. 124(2). 77–81. 4 indexed citations
16.
Mrozińska, Sandra, Tomasz Gosiewski, Magdalena Szopa, et al.. (2016). Qualitative Parameters of the Colonic Flora in Patients with HNF1A-MODY Are Different from Those Observed in Type 2 Diabetes Mellitus. Journal of Diabetes Research. 2016. 1–9. 14 indexed citations
17.
Mrozińska, Sandra, et al.. (2016). There is no difference in the plasma cortisol level between women with body mass index (BMI) greater than or equal 25 kg/m² and polycystic ovary syndrome and the control group without polycystic ovary syndrome and BMI 25 kg/m².. PubMed. 73(4). 207–9.
18.
Klupa, Tomasz, et al.. (2015). The Impact of a Pure Protein Load on the Glucose Levels in Type 1 Diabetes Patients Treated with Insulin Pumps. International Journal of Endocrinology. 2015. 1–4. 11 indexed citations
19.
Matejko, Bartłomiej, Jan Skupień, Sandra Mrozińska, et al.. (2014). Factors associated with glycemic control in adult type 1 diabetes patients treated with insulin pump therapy. Endocrine. 48(1). 164–169. 14 indexed citations
20.
Milewicz, Tomasz, et al.. (2013). [Metformin--new treatment strategies for gynecologic neoplasms].. PubMed. 70(2). 81–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Vogelaers Breakdown of academic impact, for papers by T. B. Paul Geurts Breakdown of academic impact, for papers by Emma Pinjić Breakdown of academic impact, for papers by Aleksandra Rymarz Breakdown of academic impact, for papers by Sikandar Hayat Khan Breakdown of academic impact, for papers by Nesibe Akyürek Breakdown of academic impact, for papers by H. Farouk Sadiq Breakdown of academic impact, for papers by Sergio Parco Breakdown of academic impact, for papers by A. Tuzcu Breakdown of academic impact, for papers by B Cauliez
Rankless by CCL
2026